{"id":"W4319302851","doi":"10.1016/j.jacc.2022.11.041","title":"P2Y12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions","year":2023,"lang":"en","type":"review","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"Eisai; Abiomed; Osprey Medical; Daiichi-Sankyo; Medicines Company; Boston Scientific Corporation; Eli Lilly and Company; AstraZeneca; CSL Behring; Janssen Pharmaceuticals; Gilead Sciences; Edwards Lifesciences; Amgen; Pfizer; Bayer; Daiichi Sankyo Europe; University of Bern; Sanofi; Abbott Vascular; Abbott Laboratories","keywords":"Conventional PCI; Medicine; Percutaneous coronary intervention; Internal medicine; Clinical endpoint; Cardiology; P2Y12; Clopidogrel; Stent; Myocardial infarction; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007973422,0.0008298715,0.002728123,0.001818096,0.0002063113,0.0008724012,0.0008238794,0.001052113,0.005537698],"category_scores_gemma":[0.002115389,0.0002776177,0.001218101,0.001690656,0.0002912301,0.0006444124,0.0005046704,0.001266441,0.0008188191],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003922388,"about_ca_system_score_gemma":0.00105434,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001207261,"about_ca_topic_score_gemma":0.004197729,"domain_scores_codex":[0.9996769,0.00007128238,0.00008060376,0.00005409231,0.00009026573,0.00002691384],"domain_scores_gemma":[0.999206,0.0004711253,0.0001972267,0.00001230629,0.00008458116,0.00002876582],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0006123572,0.000116492,0.0004295914,0.09700506,0.001716841,0.0001516777,0.00003622195,0.0001876707,0.0006145593,0.001268413,0.0350521,0.862809],"study_design_scores_gemma":[0.001523512,0.0009669718,0.009695597,0.09970685,0.01463377,0.002086734,0.0001380025,0.0004392443,0.000704793,0.002458888,0.8675518,0.0000938583],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001070666,0.9992169,0.00003197111,0.000113414,0.000132769,0.000004597953,0.00001718973,0.000002314502,0.00037368],"genre_scores_gemma":[0.001117832,0.9980451,0.00009872417,0.0002710699,0.0002099676,0.0000101425,0.00003561674,9.159814e-7,0.0002106726],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005537698,"threshold_uncertainty_score":0.01852542,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0823996957005993,"score_gpt":0.3608033159167613,"score_spread":0.2784036202161621,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}